Received: 22 May 2020
Accepted: 10 October 2020
First Online: 20 October 2020
Ethics approval and consent to participate
: All clinical plasma samples were provided by the Fremantle Diabetes Study (FDS), a longitudinal observational cohort. The FDS protocol was approved by the South Metropolitan Area Health Service Human Research Ethics Committee (07/397), Western Australia. All subjects gave informed consent before participation.
: Not applicable.
: SB, JI, TC, ST, KP, RL are employees of Proteomics International, with SB and RL holding shares in the company. SP, OC and HE are employees of Atturos. Proteomics International is a beneficiary of patent PCT/AU2011/001212 that relates to biomarkers described in this manuscript.